tiprankstipranks
Trending News
More News >
Ibex Ltd (IBEX)
:IBEX
US Market
Advertisement

IBEX (IBEX) AI Stock Analysis

Compare
207 Followers

Top Page

IBEX

IBEX

(NASDAQ:IBEX)

Select Model
Select Model
Select Model
Outperform 77 (OpenAI - 4o)
Rating:77Outperform
Price Target:
$42.00
▲(13.51% Upside)
IBEX's strong financial performance and positive earnings call sentiment are the most significant factors driving the score. Technical indicators support a positive outlook, while valuation is moderate. The absence of corporate events does not impact the overall assessment.
Positive Factors
Revenue Growth
IBEX's consistent revenue growth highlights its strong market position and effective business model, supporting long-term financial stability.
AI Integration
Full-scale AI deployments enhance IBEX's service offerings, providing a sustainable competitive edge and positioning the company for future growth.
Free Cash Flow
Strong free cash flow generation indicates robust cash management, enabling strategic investments and financial flexibility for IBEX.
Negative Factors
Increased SG&A Expenses
Rising SG&A expenses could pressure margins, potentially affecting profitability if not managed effectively over the long term.
Decline in Fintech Vertical
The decline in the Fintech vertical may indicate challenges in this segment, potentially impacting overall revenue diversification and growth.
Moderate Reliance on Debt
While leverage management has improved, moderate reliance on debt could pose risks if market conditions change, affecting financial stability.

IBEX (IBEX) vs. SPDR S&P 500 ETF (SPY)

IBEX Business Overview & Revenue Model

Company DescriptionIBEX is a global technology company specializing in providing digital solutions and services across various sectors, including telecommunications, healthcare, and financial services. The company focuses on developing innovative software applications, cloud-based solutions, and data analytics tools designed to enhance operational efficiency and customer engagement. IBEX's core offerings include customer experience management platforms, artificial intelligence-driven insights, and seamless integration services that cater to both enterprises and small businesses worldwide.
How the Company Makes MoneyIBEX generates revenue primarily through subscription-based models for its software and digital solutions, allowing clients to access its platforms and services on a recurring basis. Additionally, the company earns income from consulting and implementation services, where it helps businesses integrate its technologies into their existing operations. Key revenue streams include licensing fees for proprietary software, transaction fees for data analytics services, and performance-based incentives linked to customer satisfaction improvements. IBEX also partners with major technology firms and industry leaders to expand its market reach and capabilities, further driving its earnings through collaborative projects and joint ventures.

IBEX Earnings Call Summary

Earnings Call Date:Sep 11, 2025
(Q4-2025)
|
% Change Since: |
Next Earnings Date:Nov 06, 2025
Earnings Call Sentiment Positive
IBEX reported a strong fiscal year 2025 with record-breaking revenue, EBITDA, and free cash flow. The company achieved significant growth across key verticals and successfully integrated AI solutions, positioning it for future growth. Despite some increased expenses and a decline in the Fintech vertical, the company's overall performance and strategic expansions contributed to a positive outlook.
Q4-2025 Updates
Positive Updates
Record Fiscal Year Revenue
IBEX delivered record fiscal year revenue of $558.3 million, up 10% from the previous year. Q4 revenues increased by 18% from the prior year.
Strong Adjusted EBITDA and Net Income
Record adjusted EBITDA of $72 million for the fiscal year, up more than 10% from the previous year. Adjusted EPS reached $2.75, up 31% from the previous year, with adjusted net income of $43 million, up 12%.
Impressive Growth in Key Verticals
Revenue growth driven by verticals such as Retail & E-commerce (25% growth), HealthTech (19% growth), and Travel, Transportation, and Logistics (10% growth).
Strong Free Cash Flow
Record free cash flow of $27 million for the year, with $23 million generated in Q4, marking the strongest quarter ever.
Successful AI Integration
Deployment of AI solutions leading to competitive advantage. Transition from proof of concept to full-scale AI deployments in Q4, positioning the company for future growth.
Expansion into New Markets
Significant expansion into new markets like India, with strong growth in offshore revenue increasing by 17% year-over-year.
Healthy Balance Sheet
IBEX has a healthy balance sheet with $0 net debt and strong free cash flow generation.
Negative Updates
Increased SG&A Expenses
Higher selling, general, and administrative expenses related to investments in teams, technology, and expansion, impacting net income slightly.
Decline in Fintech Vertical
Exposure to the Fintech vertical decreased to 10.6% of revenue for the quarter compared to 13.7% in the prior year quarter.
Company Guidance
During the IBEX Fourth Quarter and Full Year 2025 Earnings Conference Call, the company reported record fiscal year revenue of $558.3 million, marking a 10% increase from the previous year. Fourth-quarter revenue soared by 18.2% year-over-year to $147.1 million. IBEX achieved a record adjusted EBITDA of $72 million for the fiscal year, up over 10% from the previous year, and a record adjusted EPS of $2.75, reflecting a 31% increase. The company also posted an all-time high free cash flow of $27 million for the year, with $23 million generated in Q4 alone. Looking forward, IBEX provided guidance for fiscal 2026, expecting revenues between $590 million and $610 million and adjusted EBITDA ranging from $75 million to $79 million. For the first quarter of fiscal 2026, revenue is projected to be between $143 million and $146 million, with adjusted EBITDA estimated at $17.5 million to $19 million.

IBEX Financial Statement Overview

Summary
IBEX shows strong financial performance with consistent revenue growth and profitability. The balance sheet reflects improved leverage management, and cash flow generation is robust, although there is room for improvement in cash efficiency.
Income Statement
78
Positive
IBEX has demonstrated consistent revenue growth with a 4.22% increase in the latest year, supported by a strong gross profit margin of 30.91%. The net profit margin remains stable at 6.60%, indicating effective cost management. However, the EBITDA margin has slightly decreased, suggesting potential pressure on operational efficiency.
Balance Sheet
72
Positive
The company's debt-to-equity ratio has improved to 0.52, reflecting better leverage management compared to previous years. Return on equity is strong at 27.45%, showcasing effective use of shareholder funds. However, the equity ratio indicates moderate reliance on debt, which could pose risks if not managed carefully.
Cash Flow
75
Positive
IBEX has achieved a significant free cash flow growth of 38.42%, highlighting robust cash generation capabilities. The operating cash flow to net income ratio of 0.57 suggests a healthy conversion of earnings into cash. However, the free cash flow to net income ratio indicates room for improvement in cash efficiency.
BreakdownTTMDec 2025Dec 2024Dec 2023Dec 2022Dec 2021
Income Statement
Total Revenue558.27M558.27M508.57M523.12M493.57M443.66M
Gross Profit172.58M172.58M152.03M148.13M119.60M100.40M
EBITDA64.77M63.84M60.96M60.10M52.80M51.53M
Net Income36.86M36.86M33.66M31.58M21.46M2.85M
Balance Sheet
Total Assets273.21M273.21M293.90M293.32M290.14M274.29M
Cash, Cash Equivalents and Short-Term Investments15.35M15.35M62.72M57.43M48.83M57.84M
Total Debt69.75M69.75M67.02M78.90M104.74M112.52M
Total Liabilities138.91M138.91M128.10M143.36M189.85M193.63M
Stockholders Equity134.31M134.31M165.80M149.96M100.29M80.66M
Cash Flow
Free Cash Flow27.29M27.29M27.05M22.91M24.21M5.07M
Operating Cash Flow45.67M45.67M35.90M41.86M50.13M25.90M
Investing Cash Flow-18.38M-18.38M-8.86M-19.04M-24.89M-20.17M
Financing Cash Flow-74.66M-74.66M-21.73M-13.61M-33.28M30.43M

IBEX Technical Analysis

Technical Analysis Sentiment
Positive
Last Price37.00
Price Trends
50DMA
35.79
Positive
100DMA
32.52
Positive
200DMA
28.84
Positive
Market Momentum
MACD
0.24
Positive
RSI
51.84
Neutral
STOCH
68.01
Neutral
Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For IBEX, the sentiment is Positive. The current price of 37 is below the 20-day moving average (MA) of 37.35, above the 50-day MA of 35.79, and above the 200-day MA of 28.84, indicating a bullish trend. The MACD of 0.24 indicates Positive momentum. The RSI at 51.84 is Neutral, neither overbought nor oversold. The STOCH value of 68.01 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Positive sentiment for IBEX.

IBEX Risk Analysis

IBEX disclosed 50 risk factors in its most recent earnings report. IBEX reported the most risks in the "Finance & Corporate" category.
Finance & Corporate - Financial and accounting risks. Risks related to the execution of corporate activity and strategy
Latest Risks Added 2 New Risks
1.
We are no longer a "controlled company" within the meaning of the Nasdaq Listing Rules. However, we may continue to rely on exemptions from certain corporate governance requirements during a one year phase-in period. Q1, 2025
2.
We cannot take certain actions without the consent of our largest shareholder, The Resource Group International Limited, which could limit our shareholders' ability to influence the outcome of key transactions, including any change of control. Q1, 2025

IBEX Peers Comparison

Overall Rating
UnderperformOutperform
Sector (61)
Financial Indicators
Name
Overall Rating
Market Cap
P/E Ratio
ROE
Dividend Yield
Revenue Growth
EPS Growth
$499.32M15.7424.57%9.77%34.36%
$2.40B60.6473.80%112.54%1256.46%
$490.79M30.7815.27%2.55%4.18%-51.62%
$500.35M49.59122.80%328.80%339.87%
$37.18B12.37-10.20%1.83%8.50%-7.62%
$1.22B20.0712.49%19.04%24.49%
$251.66M-2.98-1.53%78.84%
* Technology Sector Average
Performance Comparison
Ticker
Company Name
Price
Change
% Change
IBEX
IBEX
37.50
19.54
108.80%
INOD
Innodata
78.70
58.59
291.35%
HCKT
The Hackett Group
17.84
-6.03
-25.26%
UIS
Unisys
3.53
-3.38
-48.91%
TSSI
TSS
17.64
9.84
126.15%
TASK
TaskUs
13.11
0.47
3.72%

IBEX Corporate Events

IBEX Ltd’s Earnings Call Highlights Robust Growth
Sep 13, 2025

IBEX Ltd’s recent earnings call painted a picture of robust growth and strategic advancements, setting a positive tone for the company’s future. The sentiment was overwhelmingly optimistic, driven by record-breaking financial metrics and successful strategic initiatives. Despite some challenges, such as increased expenses and a dip in the Fintech vertical, IBEX’s overall performance and strategic positioning suggest a promising outlook.

Ibex Ltd Reports Record Growth and Strong Outlook
Sep 12, 2025

Ibex Ltd, a prominent player in the global business process outsourcing and customer engagement technology sector, has reported its strongest quarterly growth in nearly three years, alongside record financial results for fiscal year 2025. The company, known for its comprehensive customer engagement solutions, continues to expand its market presence and technological capabilities.

Glossary
BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.

Disclaimer

This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.Date of analysis: Oct 23, 2025